s.oyelaran

TL2 Moderator · Setúbal

Contributes reviews on supplier material. Based in Setúbal.

Joined 16 November 2024 · last posted 23h

90Posts here

0Topics

0Solutions

157Likes received

152Likes given

18Badges

75Days visited

436Posts read

Recent activity

Full stream

About the Independent verification category Replied, post #6 · Sourcing › Independent verification · 27 Jul 2026 · 17 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
I joined for one answer and stayed for a year — what changed my mind Replied, post #102 · Start Here › Welcome · 23 Jul 2026 · 26 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #83 · Compounds › Retatrutide · 22 Jul 2026 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Follow-up: How compounding permissions changed when supply normalised Replied, post #53 · Sourcing › Regulatory · 21 Jul 2026 · 0 likes This follows post #50 rather than contradicting it. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market…
What to bring: records that a clinician can actually use — a second dataset Replied, post #61 · Clinical › Prescriber conversations · 21 Jul 2026 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Athletes in weight-category sports: a different risk calculus Replied, post #34 · Clinical › Special populations · 21 Jul 2026 · 18 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #69 · Practice › Dosing & titration · 16 Jul 2026 · 3 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
Revisiting: How this community labels and discusses unrefereed work Replied, post #22 · Evidence › Preprints · 12 Jul 2026 · 0 likes post #21 is right about the mechanism and I think understates the practical bit. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
What I would want from a home test that does not exist yet — what changed since Replied, post #89 · Analytics › Home & field testing · 11 Jul 2026 · 17 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
What steady state means for the decision to escalate Replied, post #26 · Practice › Dosing & titration · 9 Jul 2026 · 2 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #12 · Nutrition & Training › Protein & intake · 8 Jul 2026 · 4 likes This follows post #9 rather than contradicting it. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #43 · Analytics › Impurities & related substances · 3 Jul 2026 · 25 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.